Literature DB >> 28487485

Supersaturated proteins in ALS.

Elliott Hayden1, Alan Cone1, Shulin Ju2.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28487485      PMCID： PMC5441790          DOI： 10.1073/pnas.1704885114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  13 in total

Review 1.  Supersaturation is a major driving force for protein aggregation in neurodegenerative diseases.

Authors:  Prajwal Ciryam; Rishika Kundra; Richard I Morimoto; Christopher M Dobson; Michele Vendruscolo
Journal:  Trends Pharmacol Sci       Date:  2015-01-27       Impact factor: 14.819

2.  A transcriptional signature of Alzheimer's disease is associated with a metastable subproteome at risk for aggregation.

Authors:  Prajwal Ciryam; Rishika Kundra; Rosie Freer; Richard I Morimoto; Christopher M Dobson; Michele Vendruscolo
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-11       Impact factor: 11.205

Review 3.  Decoding ALS: from genes to mechanism.

Authors:  J Paul Taylor; Robert H Brown; Don W Cleveland
Journal:  Nature       Date:  2016-11-10       Impact factor: 49.962

Review 4.  The complex molecular biology of amyotrophic lateral sclerosis (ALS).

Authors:  Rachel L Redler; Nikolay V Dokholyan
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

5.  Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis.

Authors:  D R Rosen; T Siddique; D Patterson; D A Figlewicz; P Sapp; A Hentati; D Donaldson; J Goto; J P O'Regan; H X Deng
Journal:  Nature       Date:  1993-03-04       Impact factor: 49.962

Review 6.  SOD1 and TDP-43 animal models of amyotrophic lateral sclerosis: recent advances in understanding disease toward the development of clinical treatments.

Authors:  Peter I Joyce; Pietro Fratta; Elizabeth M C Fisher; Abraham Acevedo-Arozena
Journal:  Mamm Genome       Date:  2011-06-26       Impact factor: 2.957

7.  Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS/TLS.

Authors:  Zhihui Sun; Zamia Diaz; Xiaodong Fang; Michael P Hart; Alessandra Chesi; James Shorter; Aaron D Gitler
Journal:  PLoS Biol       Date:  2011-04-26       Impact factor: 8.029

8.  Widespread aggregation and neurodegenerative diseases are associated with supersaturated proteins.

Authors:  Prajwal Ciryam; Gian Gaetano Tartaglia; Richard I Morimoto; Christopher M Dobson; Michele Vendruscolo
Journal:  Cell Rep       Date:  2013-10-31       Impact factor: 9.423

Review 9.  Protein aggregation in amyotrophic lateral sclerosis.

Authors:  Anna M Blokhuis; Ewout J N Groen; Max Koppers; Leonard H van den Berg; R Jeroen Pasterkamp
Journal:  Acta Neuropathol       Date:  2013-05-15       Impact factor: 17.088

Review 10.  An emerging role for misfolded wild-type SOD1 in sporadic ALS pathogenesis.

Authors:  Melissa S Rotunno; Daryl A Bosco
Journal:  Front Cell Neurosci       Date:  2013-12-16       Impact factor: 5.505
View more
  3 in total

Review 1.  Prion-like low-complexity sequences: Key regulators of protein solubility and phase behavior.

Authors:  Titus M Franzmann; Simon Alberti
Journal:  J Biol Chem       Date:  2018-06-19       Impact factor: 5.157

2.  A Genetic Screen for Human Genes Suppressing FUS Induced Toxicity in Yeast.

Authors:  Elliott Hayden; Shuzhen Chen; Abagail Chumley; Chenyi Xia; Quan Zhong; Shulin Ju
Journal:  G3 (Bethesda)       Date:  2020-06-01       Impact factor: 3.154

Review 3.  Prion-Like Proteins in Phase Separation and Their Link to Disease.

Authors:  Macy L Sprunger; Meredith E Jackrel
Journal:  Biomolecules       Date:  2021-07-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.